Annual Revenue
$50.00 M
+$50.00 M+100.00%
31 December 2023
Summary:
ProShares UltraPro Short Nasdaq Biotechnology annual revenue is currently $50.00 million, with the most recent change of +$50.00 million (+100.00%) on 31 December 2023. ZBIO annual revenue is now at all-time high.ZBIO Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$0.00
$0.000.00%
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology quarterly revenue is currently $0.00, unchanged on 30 September 2024. Over the past year, it has dropped by -$50.00 million (-100.00%). ZBIO quarterly revenue is now -100.00% below its all-time high of $50.00 million, reached on 30 September 2023.ZBIO Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$0.00
-$50.00 M-100.00%
30 September 2024
Summary:
ProShares UltraPro Short Nasdaq Biotechnology TTM revenue is currently $0.00, with the most recent change of -$50.00 million (-100.00%) on 30 September 2024. Over the past year, it has dropped by -$50.00 million (-100.00%). ZBIO TTM revenue is now -100.00% below its all-time high of $50.00 million, reached on 30 September 2023.ZBIO TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZBIO Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.0% | -100.0% | -100.0% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ZBIO Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | -100.0% | -100.0% | |||
| 5 y | 5 years | at high | -100.0% | -100.0% | |||
| alltime | all time | at high | -100.0% | -100.0% |
ProShares UltraPro Short Nasdaq Biotechnology Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 2024 | - | $0.00(0.0%) | $50.00 M(0.0%) |
| Mar 2024 | - | $0.00(0.0%) | $50.00 M(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $50.00 M(>+9900.0%) | $0.00(-100.0%) | $50.00 M(0.0%) |
| Sept 2023 | - | $50.00 M | $50.00 M |
| Dec 2022 | $0.00 | - | - |
FAQ
- What is ProShares UltraPro Short Nasdaq Biotechnology annual revenue?
- What is the all time high annual revenue for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology annual revenue year-on-year change?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly revenue?
- What is the all time high quarterly revenue for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology quarterly revenue year-on-year change?
- What is ProShares UltraPro Short Nasdaq Biotechnology TTM revenue?
- What is the all time high TTM revenue for ProShares UltraPro Short Nasdaq Biotechnology?
- What is ProShares UltraPro Short Nasdaq Biotechnology TTM revenue year-on-year change?
What is ProShares UltraPro Short Nasdaq Biotechnology annual revenue?
The current annual revenue of ZBIO is $50.00 M
What is the all time high annual revenue for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high annual revenue is $50.00 M
What is ProShares UltraPro Short Nasdaq Biotechnology annual revenue year-on-year change?
Over the past year, ZBIO annual revenue has changed by +$50.00 M (+100.00%)
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly revenue?
The current quarterly revenue of ZBIO is $0.00
What is the all time high quarterly revenue for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high quarterly revenue is $50.00 M
What is ProShares UltraPro Short Nasdaq Biotechnology quarterly revenue year-on-year change?
Over the past year, ZBIO quarterly revenue has changed by -$50.00 M (-100.00%)
What is ProShares UltraPro Short Nasdaq Biotechnology TTM revenue?
The current TTM revenue of ZBIO is $0.00
What is the all time high TTM revenue for ProShares UltraPro Short Nasdaq Biotechnology?
ProShares UltraPro Short Nasdaq Biotechnology all-time high TTM revenue is $50.00 M
What is ProShares UltraPro Short Nasdaq Biotechnology TTM revenue year-on-year change?
Over the past year, ZBIO TTM revenue has changed by -$50.00 M (-100.00%)